Trial Profile
Clinical Trials Insight: 700021346
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 23 Aug 2023
Price :
$35
*
At a glance
- Drugs Carvedilol (Primary)
- Indications Essential hypertension
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 05 Mar 2007 New trial record.